{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 52,
        "end": 63
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 67,
        "end": 78
      }
    },
    {
      "id": "T3",
      "obj": "Disease",
      "span": {
        "begin": 111,
        "end": 124
      }
    },
    {
      "id": "T5",
      "obj": "Disease",
      "span": {
        "begin": 203,
        "end": 222
      }
    },
    {
      "id": "T7",
      "obj": "Disease",
      "span": {
        "begin": 127,
        "end": 143
      }
    },
    {
      "id": "T10",
      "obj": "Disease",
      "span": {
        "begin": 147,
        "end": 172
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "18573584_4",
  "text": "METHODS : In total 56 patients acutely treated with haloperidol or risperidone either for the first episode of schizophrenia , schizophreniform or schizoaffective disorders , or for the relapse of these psychotic disorders after tapering their maintenance treatment , were genotyped for the 5-HTTLPR L and S alleles and for the new A/G functional variant within the L alelle ( La/g ) ."
}
